Browse
Submit Data
Databases
API
Help

Dataset Information

21 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

6-Meth-oxy-2-methyl-1-m-tolyl-1H-benzimidazole hemihydrate.

ABSTRACT: The title compound, C(16)H(16)N(2)O·0.5H(2)O, is a substituted 1-phenyl-benzimidazole, which belongs to the class of ATP-site inhibitors of the platelet-derived growth-factor receptor. In the crystal, the components are linked by an O-H?N hydrogen bond.

SUBMITTER: Fang XB

PROVIDER: S-EPMC3200643 | biostudies-literature | 2011 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

6-Meth-oxy-2-methyl-1-m-tolyl-1H-benzimidazole hemihydrate.

Fang Xu-Bin XB Fang Lei L Liu Xu-Ying XY

Acta crystallographica. Section E, Structure reports online 20110806 Pt 9

The title compound, C(16)H(16)N(2)O·0.5H(2)O, is a substituted 1-phenyl-benzimidazole, which belongs to the class of ATP-site inhibitors of the platelet-derived growth-factor receptor. In the crystal, the components are linked by an O-H⋯N hydrogen bond. ...[more]

PMID: 22064843

Similar Datasets

2-p-Tolyl-1-p-tolyl-methyl-1H-benzimidazole.

Project description:The asymmetric unit of the title compound, C(22)H(20)N(2), contains two crystallographically independent mol-ecules in which the planar benzimidazole ring systems are oriented with respect to the adjacent tolyl rings at dihedral angles of 47.08?(8)/76.85?(8) and 39.52?(9)/87.49?(9)°, while the dihedral angles between the tolyl rings are 73.99?(3) and 81.51?(9)°. In the crystal structure, pairs of inter-molecular C-H?N inter-actions link one of the asymmetric mol-ecules into centrosymmetric dimers through R(2) (2)(8) ring motifs.

| S-EPMC2969414 | biostudies-other

1-Isopropyl-4-nitro-6-meth-oxy-1H-benzimidazole.

Project description:There are two independent mol-ecules in the asymmetric unit of the title compound, C(11)H(13)N(3)O(3). The inter-planar angles for the two rings of the benzimidazole ring system is 2.21?(12)° in one mol-ecule and 0.72?(12)° in the other. The nitro group is twisted in the same direction relative to the least-squares plane through its attached benzene ring in both mol-ecules, with inter-planar angles of 15.22?(9) and 18.02?(8)°. In the crystal structure, mol-ecules are stacked along the a axis through ?-? inter-actions (centroid-centroid distance 4.1954?Å). C-H?O hydrogen bonds are also present.

| S-EPMC2961682 | biostudies-literature

2-[4-(Trifluoro-meth-oxy)phen-yl]-1H-benzimidazole.

Project description:In the title compound, C(14)H(9)F(3)N(2)O, the best planes of the benzimidazole group and benzene ring form a dihedral angle of 26.68 (3)°. In the crystal, N-H⋯N hydrogen bonds link the mol-ecules into infinite chains parallel to the c axis. Stacking inter-actions between the benzimidazole groups [centroid-centroid distance = 3.594 (5) Å] assemble the mol-ecules into layers parallel to (100). The trifluoro-methyl group is disordered over three sets of sites with site-occupancy factors of 0.787 (4), 0.107 (7) and 0.106 (7).

| S-EPMC3569794 | biostudies-literature

2-(4-Meth-oxy-phen-yl)-1-phenyl-1H-benzimidazole.

Project description:In the title compound, C(20)H(16)N(2)O, the 1H-benzimidazole ring forms dihedral angles of 48.00 (6) and 64.48 (6)°, respectively with the benzene and phenyl rings, which are inclined to one another by 58.51 (7)°. In the crystal, weak C-H⋯π inter-actions are the only inter-molecular inter-actions present.

| S-EPMC3569798 | biostudies-literature

1-Phenyl-2-p-tolyl-1H-benzimidazole.

Project description:In the title compound, C20H16N2, the benzimidazole ring system forms dihedral angles of 28.50?(7) and 72.44?(7)° with the tolyl and phenyl rings, respectively. In the crystal, mol-ecules are linked into chains along the a-axis direction by weak C-H?N inter-actions. The crystal structure also features C-H?? inter-actions.

| S-EPMC3588497 | biostudies-literature

N-(1-Allyl-1H-indazol-5-yl)-4-meth-oxy-benzene-sulfonamide hemihydrate.

Project description:In the title compound, C17H17N3O3 (.)0.5H2O, the indazole system makes a dihedral angle of 46.19?(8)° with the plane through the benzene ring and is nearly perpendicular to the allyl group, as indicated by the dihedral angle of 81.2?(3)°. In the crystal, the water mol-ecule, disordered over two sites related by an inversion center, forms O-H?N bridges between indazole N atoms of two sulfonamide mol-ecules. It is also connected via N-H?O inter-action to the third sulfonamide mol-ecule; however, due to the water mol-ecule disorder, only every second mol-ecule of sulfonamide participates in this inter-action. This missing inter-action results in a slight disorder of the sulfonamide S,O and N atoms which are split over two sites with half occupancy. With the help of C-H?O hydrogen bonds, the mol-ecules are further connected into a three-dimensional network.

| S-EPMC3790445 | biostudies-literature

Ethyl 1-(4-meth-oxy-benz-yl)-3-p-tolyl-1H-pyrazole-5-carboxyl-ate.

Project description:In the title compound, C(21)H(22)N(2)O(3), the pyrazole ring makes dihedral angles of 12.93?(8) and 69.38?(8)°, respectively, with the tolyl and meth-oxy-benzyl rings.

| S-EPMC3089161 | biostudies-literature

Methyl 4-(5-meth-oxy-1H-indol-3-yl)benzoate.

Project description:In the title compound, C(17)H(15)NO(3), the dihedral angle between the benzene ring and the indole ring system is 22.5?(3)°. In the crystal, mol-ecules are linked by N-H?? and C-H?O inter-actions.

| S-EPMC3254479 | biostudies-literature

1-{2-Phenyl-2-[4-(trifluoro-meth-yl)-benzyl-oxy]eth-yl}-1H-benzimidazole.

Project description:The asymmetric unit of the crystal structure of the title compound, C(23)H(19)F(3)N(2)O, contains two independent mol-ecules. In the two mol-ecules the planar benzimidazole ring systems are oriented with respect to the phen-yl/trifluoro-methyl-benzene rings at dihedral angles of 9.62 (6)/78.63 (7) and 2.53 (8)/83.83 (9)°. In the crystal structure, inter-molecular C-H⋯N hydrogen bonds link the mol-ecules into R(2) (2)(6) dimers. The mol-ecules are elongated along [001] and stacked along the b axis.

| S-EPMC2962243 | biostudies-literature

(E)-4-Meth-oxy-N'-(2,4,5-tri-meth-oxy-benzyl-idene)benzohydrazide hemihydrate.

Project description:The title compound crystallizes as a hemihydrate, C18H20N2O5·0.5H2O. The mol-ecule exists in an E conformation with respect to the C=N imine bond. The 4-meth-oxy-phenyl unit is disordered over two sets of sites with a refined occupancy ratio of 0.54 (2):0.46 (2). The dihedral angles between the benzene rings are 29.20 (9) and 26.59 (9)°, respectively, for the major and minor components of the 4-meth-oxy-substituted ring. All meth-oxy substituents lie close to the plane of the attached benzene rings [the Cmeth-yl-O-C-C torsion angles range from -4.0 (12) to 3.9 (2)°]. In the crystal, the components are linked into chains propagating along [001] via N-H⋯O and O-H⋯O hydrogen bonds and weak C-H⋯O inter-actions.

| S-EPMC3998312 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data